Holborn Wells India sets up Pharma and Medical Devices Regulatory Affairs Consulting Division as Make in India marks its 8th year

Holborn Wells India, an IVD manufacturing company, released a statement that it has launched a Pharmaceutical & Medical Devices Regulatory consulting division to assist local start-ups and consult foreign companies looking to invest in India in the Pharma & Medical Device sector.

New Delhi [India], September 26 (ANI/BusinessWire India): Holborn Wells India, an IVD manufacturing company, released a statement that it has launched a Pharmaceutical & Medical Devices Regulatory consulting division to assist local start-ups and consult foreign companies looking to invest in India in the Pharma & Medical Device sector. Over the last few months, Holborn Wells India had multiple queries from various Indian start-ups as well as from Europe & North America related to regulatory landscape & setting up a manufacturing base in India. The company is not only able to assist with documentation as per CDSCO guidelines, but with the extensive technical & regulatory experience as a Medical Device Manufacturer, The company is able to deliver end-to-end services including technical, legal & contract manufacturing services through the channel partners. The intent is to assist the nation in attracting Foreign Direct Investments & act as a catalyst to support "Start-up India" initiative set up by Prime Minister Narendra Modi.

According to Lawrence Perry, Head of International Sales for Holborn Wells India, the Indian market and "Make in India" policy has created a huge platform for various international companies looking to setup bases in India. With liberalized guidelines and regulations, reduction in unnecessary compliance burden, cost reduction and ease of doing business in India, Holborn Wells India expects to see tremendous interest in India because of the "Make in India" initiative. This story has been provided by BusinessWire India. ANI will not be responsible in any way for the content in this article. (ANI/BusinessWire India)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)